In this article we will explore a wide range of ideas and concepts related to Bipolar disorder not otherwise specified. From its origin to its current applications, Bipolar disorder not otherwise specified has been a topic of interest and debate in various areas. We will analyze its importance in contemporary society, as well as its influence on the development of different disciplines. Through research and interviews with experts, we will seek to shed light on the most relevant aspects related to Bipolar disorder not otherwise specified, providing our readers with a more complete and in-depth vision of this topic.
Bipolar disorder NOS | |
---|---|
Specialty | Psychiatry |
Bipolar disorder not otherwise specified (BD-NOS) is a diagnosis for bipolar disorder (BD) when it does not fall within the other established sub-types. Bipolar disorder NOS is sometimes referred to as subthreshold bipolar disorder.
BD-NOS is a mood disorder and one of four subtypes on the bipolar spectrum, which also includes bipolar I disorder, bipolar II disorder, and cyclothymia. BD-NOS was a classification in the DSM-IV and has since been changed to Bipolar "Other Specified" and "Unspecified" in the 2013 released DSM-5 (American Psychiatric Association, 2013). BD-NOS is a disorder which creates intense mood instability which causes bouts of depression, hypomania, and mania, and occasionally mood stability.
Bipolar disorder is difficult to diagnose. If a person displays some symptoms of bipolar disorder but not others, the clinician may diagnose bipolar NOS. The diagnosis of bipolar NOS is indicated when there is a rapid change (days) between manic and depressive symptoms and can also include recurring episodes of hypomania. Bipolar NOS may be diagnosed when it is difficult to tell whether bipolar is the primary disorder due to another general medical condition, such as a substance use disorder. A diagnosis of this condition can be challenging and is often imprecise.
Individual approaches to treatment are recommended, usually involving a combination of mood stabilizers and atypical antipsychotics. Psychotherapy may be beneficial and should be started early.
The prevalence of BD-NOS is 1.4%.